Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2008;103:53-60
Published online before print June 5, 2008, doi: 10.1161/CIRCRESAHA.108.176321
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
103/1/53    most recent
CIRCRESAHA.108.176321v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Sugiura, T.
Right arrow Articles by Roberts, J. D.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sugiura, T.
Right arrow Articles by Roberts, J. D., Jr
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Nucleotide
*Protein*UniGene
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Pulmonary circulation and disease
Right arrow Smooth muscle proliferation and differentiation
(Circulation Research. 2008;103:53.)
© 2008 American Heart Association, Inc.


Molecular Medicine

Proteolytic Processing of cGMP-Dependent Protein Kinase I Mediates Nuclear cGMP Signaling in Vascular Smooth Muscle Cells

Takahiro Sugiura, Hidehiko Nakanishi, Jesse D. Roberts, Jr

From the Cardiovascular Research Center, Departments of Anesthesia (T.S., H.N., J.R.), Pediatrics (J.R.), and Medicine (J.R.), Massachusetts General Hospital, Boston; and Harvard Medical School.

Correspondence to Jesse Roberts Jr, MD, MGH-East, CVRC 4th Floor, 149 13th Street, Charlestown MA 02129. E-mail roberts{at}cvrc.mgh.harvard.edu

Cyclic GMP modulates gene expression in vascular smooth muscle cells (SMCs) in part by stimulating cGMP-dependent protein kinase I (PKGI) and the phosphorylation of transcription factors. In some cells, cGMP increases nuclear translocation of PKGI and PKGI-dependent phosphorylation of transcription regulators; however, these observations have been variable, and the mechanisms mediating nuclear PKGI translocation are incompletely understood. We tested the hypothesis that proteolytic cleavage of PKGI is required for cGMP-stimulated nuclear compartmentation of PKGI and phosphorylation of transcription factors. We detected an NH2-terminal PKGI fragment with leucine zipper domain immunoreactivity in the cytosol and endoplasmic reticulum of SMCs, but only a COOH-terminal PKGI fragment containing the catalytic region (now termed PKGI{gamma}) was observed in the Golgi apparatus (GA) and nucleoplasm. Posttranslational PKGI processing in the GA was critical for nuclear compartmentation of PKGI{gamma} because GA disruption with nocodazol or brefeldin A inhibited PKGI{gamma} nuclear localization. PKGI{gamma} immunoreactivity was particularly abundant in the nucleolus of interphase SMCs where its colocalization with the nucleolar dense fibrillar component protein fibrillarin closely matched the level of nucleolar assembly. Purified nucleolar PKGI{gamma} enzyme activity was insensitive to cGMP stimulation, which is consistent with its lack of the NH2-terminal autoinhibitory domain. Mutation of a putative proteolytic cleavage region in PKGI inhibited cGMP-mediated phosphorylation of cAMP response element-binding protein, cAMP response element-dependent transcription, and nuclear localization of PKGI{gamma}. These observations suggest that posttranslational modification of PKGI critically influences the nuclear translocation of PKGI and activities of cGMP in SMCs.


Key Words: cGKI • guanylate cyclase • gene expression regulation • signal transduction • vascular disease